Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes. An Electronic Medication Monitoring Study

Journal of the American College of Cardiology

Volumn 48, Issue 11, 2006, Pages 2218-2222

  Rieckmann, Nina ^a   Gerin, William ^b   Kronish, Ian M ^a   Burg, Matthew M ^b   Chaplin, William F ^d   Kong, Grace ^d   Lespérance, François ^c   Davidson, Karina W ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; COURSE EVALUATION; DEPRESSION; DISEASE SEVERITY; DRUG MONITORING; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SAMPLE SIZE; SCORING SYSTEM; SYMPTOM; THERAPY EFFECT; TREATMENT REFUSAL;

EID: 33845207049     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.07.063     Document Type: Article

References (20)

1. DiMatteo M.R., Giordani P.J., Lepper H.S., and Croghan T.W. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40 (2002) 794-811
2. Eagle K.A., Kline-Rogers E., Goodman S.G., et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 117 (2004) 73-81
3. Sud A., Kline-Rogers E.M., Eagle K.A., et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother 39 (2005) 1792-1797
4. Dartnell J.G., Anderson R.P., Chohan V., et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 164 (1996) 659-662
5. Horwitz R.I., Viscoli C.M., Donaldson R.M., et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 336 (1990) 542-545
6. Psaty B.M., Koepsell T.D., Wagner E.H., LoGerfo J.P., and Inui T.S. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA 263 (1990) 1653-1657
7. DiMatteo M.R., Lepper H.S., and Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
8. Carney R.M., Freedland K.E., Eisen S.A., Rich M.W., and Jaffe A.S. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 14 (1995) 88-90
9. Gehi A., Haas D., Pipkin S., and Whooley M.A. Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med 165 (2005) 2508-2513
10. Thombs B.D., Bass E.B., Ford D.E., et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 21 (2006) 30-38
11. Barth J., Schumacher M., and Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66 (2004) 802-813
12. Zellweger M.J., Osterwalder R.H., Langewitz W., and Pfisterer M.E. Coronary artery disease and depression. Eur Heart J 25 (2004) 3-9
13. Ziegelstein R.C., Fauerbach J.A., Stevens S.S., Romanelli J., Richter D.P., and Bush D.E. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 160 (2000) 1818-1823
14. Beck A.T., and Steer R.A. Manual for the Beck Depression Inventory (1993), Psychological Corp, San Antonio, TX
15. Lespérance F., Frasure-Smith N., Talajic M., and Bourassa M.G. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105 (2002) 1049-1053
16. Frasure-Smith N., Lespérance F., and Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91 (1995) 999-1005
17. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
18. Arbuckle J.A., and Wothke W. AMOS 4.0 User's Guide (1999), SPSS Inc, Chicago, IL
19. McDonald H.P., Garg A.X., and Haynes R.B. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 288 (2002) 2868-2879
20. Haynes R.B., Yao X., Degani A., Kripalani S., Garg A., and McDonald H.P. Interventions to enhance medication adherence. Cochrane Database Syst Rev (2005) CD000011